about
MRI correlates of disability progression in patients with CIS over 48 months.Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients.Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients.Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach.Reliable measurements of brain atrophy in individual patients with multiple sclerosis.Cerebrospinal fluid IL-8 levels reflect symptoms of alexithymia in patients with non-inflammatory neurological disorders.Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients.Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome.Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a.Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome.Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients.GABA spectra and remote distractor effect in progressive supranuclear palsy: A pilot study.
P50
Q34431806-B592A5CC-AD12-41FC-B9CB-E9DB6E543CBCQ36093231-67A02628-6B0C-46A5-A7AF-349A1DB79C6CQ38654791-ADF514B5-60BB-45EE-ABB1-E52D5F92C170Q39165460-EC33D418-C5D9-43C7-9251-3A6305A787ADQ39335452-9B145747-239D-4C6F-A36B-D67AC8B871CBQ43502192-E9FCFD8B-B263-4625-96F8-B074CB3FB89DQ47924597-6665759D-31A4-4A4D-B7A9-E30AB3333CD2Q48108313-54BC1DA1-EA9F-40DA-A156-5A96A38D74BBQ48215414-78733CF9-F4B0-4A18-AEAB-6261AAE415DCQ48704199-3EAC27FD-A73B-4DE2-AB1D-2B87B9CF81B0Q48711608-32A97332-3097-4D8B-8802-0AC6778EF380Q48901292-112900F0-CDD5-4ED1-BCD8-4850C9C29F5AQ50927521-826BA368-544D-4DA0-A62A-7C8D1B373EEE
P50
description
investigador
@es
researcher
@en
name
Tomas Uher
@en
type
label
Tomas Uher
@en
prefLabel
Tomas Uher
@en
P31
P496
0000-0002-3241-4713